EU governments ban malaria drug for COVID-19, trial paused as safety fears grow
European governments moved on Wednesday to halt the use of anti-malaria drug hydroxychloroquine to treat COVID-19 patients, and a second global trial was suspended, further blows to hopes for a treatment promoted by U.S. President Donald Trump. (Source: Reuters: Health)
Source: Reuters: Health - May 27, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

WHO Expects Hydroxychloroquine Safety Findings by Mid-June WHO Expects Hydroxychloroquine Safety Findings by Mid-June
WHO on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug's use in a trial on COVID-19 patients.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 27, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

FDA Approves IV Artesunate for Severe Malaria
WEDNESDAY, May 27, 2020 -- Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday. This approval marks the first for severe malaria... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 27, 2020 Category: General Medicine Source Type: news

Indonesia, Major Advocate of Hydroxychloroquine, Told by WHO to Stop Using It Indonesia, Major Advocate of Hydroxychloroquine, Told by WHO to Stop Using It
WHO has urged Indonesia, one of the world's biggest advocates of two malaria drugs to treat the coronavirus, to suspend such treatment over safety concerns, a source familiar with the advice told Reuters on Tuesday.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 27, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears
France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19, the illness caused by the new coronavirus, amid questions about the safety of the generic anti-malaria drug. (Source: Reuters: Health)
Source: Reuters: Health - May 27, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 over safety fears
France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19, the illness caused by the novel coronavirus, amid questions about the safety of the generic anti-malaria drug. (Source: CBC | Health)
Source: CBC | Health - May 27, 2020 Category: Consumer Health News Tags: News/World Source Type: news

USAMRDC announces FDA licensure for severe malaria treatment
(Walter Reed Army Institute of Research) The US Army Medical Research and Development Command announced today that the US Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria. The drug was developed under current Good Manufacturing Practices by the Walter Reed Army Institute of Research and the US Army Medical Materiel Development Activity, subordinate commands of USAMRDC. The only other FDA-approved treatment option, intravenous quinidine, was discontinued in 2019. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 27, 2020 Category: Infectious Diseases Source Type: news

FDA Approves Artesunate for Injection for the Treatment of Severe Malaria
FREDERICK, Md., May 27, 2020 /PRNewswire/ -- Amivas (US), LLC, specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today that Artesunate for Injection 110 mg, powder and solvent for solution has... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 27, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Only Drug in U.S. to Treat Severe Malaria
FDA has approved artesunate for injection to treat severe malaria in adult and pediatric patients. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

WHO expects hydroxychloroquine safety findings by mid-June
The World Health Organization (WHO) on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug's use in a large trial on COVID-19 patients. (Source: Reuters: Health)
Source: Reuters: Health - May 26, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Factbox: Key upcoming clinical trials of hydroxychloroquine, touted by Trump, for COVID-19
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to potential safety risks but other studies testing the medicine are continuing. (Source: Reuters: Health)
Source: Reuters: Health - May 26, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 26, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

WHO pauses hydroxychloroquine from drug study, warns of possible "second peak" of coronavirus
The World Health Organization (WHO) has temporarily suspended the malaria drug hydroxychloroquine from a global trial for COVID-19 treatments for a safety review. Dr. David Agus joins "CBS This Morning" to explain why the drug was dropped from the global study. He also addresses the WHO warning that countries reopening could face an "immediate second peak" of the virus if safety measures are lifted too soon. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 26, 2020 Category: Consumer Health News Source Type: news

WHO Halts Testing of Drug That President Trump Has Embraced
TUESDAY, May 26, 2020 -- Safety concerns over a malaria drug that President Donald Trump has touted as a coronavirus treatment prompted the World Health Organization on Monday to remove the medication from a global trial of potential COVID-19... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2020 Category: General Medicine Source Type: news

Anti-malarial drug shows promise for brain cancer treatment
(Virginia Commonwealth University) Glioblastoma multiforme (GBM) is an aggressive form of cancer in the brain that is typically fatal. But new findings by VCU Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) researchers could help increase the effectiveness of the most common current treatments with the addition of lumefantrine, an FDA-approved drug used to treat malaria. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 26, 2020 Category: Cancer & Oncology Source Type: news

WHO Suspends Study of Hydroxychloroquine as COVID-19 Treatment to Review Safety Concerns
(GENEVA) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date. In a press briefing, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems, there would be “a temporary pause” on the hydroxychloroquine arm of its g...
Source: TIME: Health - May 25, 2020 Category: Consumer Health News Authors: Maria Cheng and Jamey Keaten / AP Tags: Uncategorized COVID-19 News Desk overnight wire Source Type: news

World Health Organization temporarily halts hydroxychloroquine trials
The World Health Organization says it is temporarily dropping hydroxychloroquine — the malaria drug U.S. President Donald Trump said he was taking — from its global study into experimental COVID-19 treatments. (Source: CBC | Health)
Source: CBC | Health - May 25, 2020 Category: Consumer Health News Tags: News/World Source Type: news

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 25, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

WHO halts hydroxychloroquine trial for coronavirus amid safety fears
Malaria drug taken by Trump could raise risk of death and heart problems, study showsCoronavirus – latest updatesSee all our coronavirus coverageThe World Health Organization has said it will temporarily drop hydroxychloroquine — the malaria drug Donald Trump said he is taking as a precaution — from its global study into experimental coronavirus treatments after safety concerns.The WHO ’s director-general Tedros Adhanom Ghebreyesus said in light ofa paper published last week in the Lancetthat showed people taking hydroxychloroquine were at higher risk of death and heart problems than those who were ...
Source: Guardian Unlimited Science - May 25, 2020 Category: Science Authors: Staff and agencies Tags: World Health Organization Epidemics Coronavirus outbreak Infectious diseases Medical research Microbiology Science Society World news Source Type: news

Establishing injury surveillance in emergency departments in Nepal: protocol for mixed methods prospective study - Magnus D, Bhatta S, Mytton J, Joshi E, Bird EL, Bhatta S, Manandhar SR, Joshi SK.
BACKGROUND: Globally, injuries cause more than 5 million deaths annually, a similar number to those from HIV, Tuberculosis and Malaria combined. In people aged between 5 and 44  years of age trauma is the leading cause of death and disability and the burd... (Source: SafetyLit)
Source: SafetyLit - May 24, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

U.S. veterans agency has given hydroxychloroquine to 1,300 coronavirus patients
The U.S. Department of Veterans Affairs (VA) has treated 1,300 coronavirus patients with the malaria drug hydroxychloroquine, which a study has tied to an increased risk of death, according to a document released by a Senate Democrat on Friday. (Source: Reuters: Health)
Source: Reuters: Health - May 22, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Malaria Drug Taken by Trump Is Tied to Increased Risk of Heart Problems and Death in New Study
The drugs did not help coronavirus patients, and should not be used outside clinical trials, researchers said. (Source: NYT Health)
Source: NYT Health - May 22, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Hydroxychloroquine (Drug) Azithromycin (Drug) Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Malaria Clinical Trials Food and Drug Administration Lancet, The (Journal) Trump, Donald J your-feed-healthcare Source Type: news

Drug touted by Trump as COVID-19 treatment tied to increased risk of death: study
The malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to increased risk of death in hospitalized COVID-19 patients, according to a large study published in the medical journal Lancet. (Source: Reuters: Health)
Source: Reuters: Health - May 22, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Big study casts more doubt on malaria drugs for coronavirus
A large new study suggests that malaria drugs pushed by President Donald Trump as treatments for the coronavirus not only do not help but also are tied to a greater risk of death and heart rhythm problems (Source: ABC News: Health)
Source: ABC News: Health - May 22, 2020 Category: Consumer Health News Tags: Health Source Type: news

Hydroxychloroquine: Trump's Covid-19 'cure' increases deaths, global study finds
Malaria drug should not be used to treat coronavirus, scientists say, after study shows high death rateCoronavirus – latest updatesSee all our coronavirus coverageHydroxychloroquine, the anti-malarial drugDonald Trump is taking to prevent Covid-19, has increased deaths in patients treated with it in hospitals around the world, a study has shown.A major study of the way hydroxychloroquine and its older version, chloroquine, have been used on six continents – without clinical trials – reveals a sobering picture. Scientists said the results meant the drug should no longer be given to Covid-19 patients except...
Source: Guardian Unlimited Science - May 22, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Drugs Health Coronavirus outbreak Science Society World news Donald Trump Infectious diseases Source Type: news

Large Study Finds No Benefit — and Potential Harm — in Using Hydroxychloroquine for COVID-19
In the largest observational study thus far investigating the drug hydroxychloroquine as a treatment for COVID-19, researchers found little evidence that it helps, and worrying evidence that the medication may cause harm. In a study published May 22 in the journal Lancet, scientists in the U.S. and Switzerland report on an analysis of more than 96,000 people hospitalized with confirmed COVID-19 in 671 hospitals on six continents. Nearly 15,000 patients were treated with one of the following: chloroquine (which is an older version of hydroxychloroquine), hydroxychloroquine, or either of those drugs in combination with an an...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

Large Study Finds No Benefit — and Potential Harm — in Using Hydroxychloroquine for COVID-19
In the largest observational study thus far investigating the drug hydroxychloroquine as a treatment for COVID-19, researchers found little evidence that it helps, and worrying evidence that the medication may cause harm. In a study published May 22 in the journal Lancet, scientists in the U.S. and Switzerland report on an analysis of more than 96,000 people hospitalized with confirmed COVID-19 in 671 hospitals on six continents. Nearly 15,000 patients were treated with one of the following: chloroquine (which is an older version of hydroxychloroquine), hydroxychloroquine, or either of those drugs in combination with an an...
Source: TIME: Science - May 22, 2020 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

‘Could It Work as a Cure? Maybe.’ A Herbal Remedy for Coronavirus Is a Hit in Africa, But Experts Have Their Doubts
On April 20, the president calls a press conference to announce a breakthrough in the fight against COVID-19. It’s a new use for an old malaria treatment, he says, one that is seeing miraculous results among the country’s most ill patients. It’s so safe that even schoolchildren could take it. In fact, he urges them to do so daily, as a preventative. He admits that he, too, is taking the medicine. No, this is not the President of the United States touting an unproven remedy for a virus that has infected nearly 5 million people worldwide. It is Madagascar’s President Andry Rajoelina, who is just as wi...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 overnight Source Type: news

Brazil's Bolsonaro accepts no proof chloroquine works, but may work in some cases
Brazil President Jair Bolsonaro, a long-running advocate of malaria drug chloroquine to treat COVID-19, said on Thursday he knew there was no proof it works, but said there are cases in which it appears to have been successful. (Source: Reuters: Health)
Source: Reuters: Health - May 22, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Why More Must be Done to Fight Bogus COVID-19 Cure Claims
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Why More Must be Done to Fight Bogus COVID-19 Cure Claims appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - May 21, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

Africa: Four Ways to Combat Malaria in the Time of COVID-19
[allAfrica] Globally there are more than 5.1 million cases of COVID-19 with most cases currently in high income countries. The U.S. and Europe are responsible for 72% of COVID-19 cases, 63% of recoveries and 82% of deaths. In contrast, World Health organization estimates there were 228 million cases of malaria and 405,000 deaths due to malaria worldwide in 2018. Africa bore the burden of these statistics, accounting for 93% of malaria cases and 94% of malaria deaths. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 21, 2020 Category: African Health Source Type: news

WHO: Drug Trump taking to fight COVID-19 best left to tests
The World Health Organization says the science is still unclear on an anti-malaria drug that U.S. President Donald Trump is taking to try to defend against the new coronavirus, and recommends its use for COVID-19 only in controlled clinical trials for now (Source: ABC News: Health)
Source: ABC News: Health - May 21, 2020 Category: Consumer Health News Tags: Health Source Type: news

Trump says his hydroxychloroquine regimen finishes in the next day or two
U.S. President Donald Trump said on Wednesday the regimen of an anti-malaria drug hydroxychloroquine that he is taking to ward off the coronavirus finishes in the next day or two. (Source: Reuters: Health)
Source: Reuters: Health - May 20, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Humans Inoculated with Genetically Modified Malaria Parasites
Engineered Plasmodium parasites form the basis of two experimental malaria vaccines that showed safety and encouraging immune responses in clinical trials. (Source: The Scientist)
Source: The Scientist - May 20, 2020 Category: Science Tags: News & Opinion Source Type: news

Namibia: Malaria Deaths At 32
[Namibian] HEALTH minister Kalumbi Shangula says 32 people died of malaria since January 2020. Responding to questions from The Namibian this week, Shangula said malaria cases jumped from 2 405 in 2019 to 10 921 since January 2020 to date. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - May 20, 2020 Category: Infectious Diseases Source Type: news

Fact check: Trump falsely denies FDA warning on hydroxychloroquine, baselessly alleges political bias in study
President Donald Trump continued Tuesday to make false and baseless claims about hydroxychloroquine, the anti-malaria drug he has repeatedly promoted and now says he is himself taking. (Source: CNN.com - Health)
Source: CNN.com - Health - May 20, 2020 Category: Consumer Health News Source Type: news

President Trump Defends His Hydroxychloroquine Use Amid Concerns, Says ‘So Far I Seem to Be O.K.’
(WASHINGTON) — President Donald Trump emphatically defended himself Tuesday against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans of the unproven treatment with potentially fatal side effects. Trump’s revelation a day earlier that he was taking hydroxychloroquine caught many in his administration by surprise and set off an urgent effort by officials to justify his action. But their attempt to address the concerns of health professionals was undercut by the president himself. He asserted without evidence that a study raising a...
Source: TIME: Health - May 20, 2020 Category: Consumer Health News Authors: ZEKE MILLER, MARILYNN MARCHIONE and JONATHAN LEMIRE / AP Tags: Uncategorized COVID-19 Donald Trump News Desk wire Source Type: news

Zimbabwe: Mutoko Clinics Turn Away Malaria Patients in Fear of COVID-19
[New Zimbabwe] Clinics in Mutoko are reportedly turning away patients seeking treatment for malaria in fear staff could be infected with the deadly coronavirus. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - May 20, 2020 Category: Infectious Diseases Source Type: news

Trump attacks study, defends using malaria drug for COVID-19
President Donald Trump attacked the validity of a study of veterans that raised alarms about the malaria drug he actively promotes as a treatment for the coronavirus (Source: ABC News: Health)
Source: ABC News: Health - May 20, 2020 Category: Consumer Health News Tags: Health Source Type: news

First clinical trial with genetically modified malaria vaccine completed
(Radboud University Medical Center) In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2020 Category: Infectious Diseases Source Type: news

Malaria vaccines based on engineered parasites show safety, signs of efficacy
(American Association for the Advancement of Science) Two vaccines for malaria based on genetically engineered malaria parasites have been found to be safe in humans and show preliminary signs of protection, according to a pair of new phase 1/2a clinical trials. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2020 Category: Infectious Diseases Source Type: news

My 'decision to make': Trump defends criticized use of drug
President Donald Trump is emphatically defending himself against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans (Source: ABC News: Health)
Source: ABC News: Health - May 20, 2020 Category: Consumer Health News Tags: Health Source Type: news

Trump defends his use of unproven treatment as prevention against coronavirus
U.S. President Donald Trump on Tuesday defended taking a prescription malaria drug to try to ward off the novel coronavirus despite medical warnings about its use. (Source: Reuters: Health)
Source: Reuters: Health - May 20, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Trump Says He Is Taking Hydroxychloroquine as Hedge Against Virus Trump Says He Is Taking Hydroxychloroquine as Hedge Against Virus
US President Donald Trump said on Monday he is taking hydroxychloroquine, a malaria drug that he has touted despite medical warnings about its use, as a preventive medicine against the coronavirus.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 19, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Despite risks, Trump says he's taking hydroxychloroquine
The White House is hurrying to defend President Donald Trump's decision to take a malaria drug he's been touting as as a treatment for the coronavirus (Source: ABC News: Health)
Source: ABC News: Health - May 19, 2020 Category: Consumer Health News Tags: Health Source Type: news

What you need to know today about the virus outbreak
The White House is defending President Donald Trump’s decision to take a malaria drug he’s been promoting as a treatment for the coronavirus (Source: ABC News: Health)
Source: ABC News: Health - May 19, 2020 Category: Consumer Health News Tags: Health Source Type: news

Has Trump been trying out his own dodgy medical advice? It would explain a few things | Arwa Mahdawi
The president has announced he is taking hydroxychloroquine to fight coronavirus. Perhaps he has also been injecting bleach in front of Fox NewsHow is Donald Trump still alive? Seriously, it defies science. The man reportedly drinks12 Diet Cokes a day, appears to exist purely onBig Macs and doesn ’t do any exercise because he thinks thehuman body is like a battery and working out depletes it. On top of all this, it turns out the 73-year-old is popping pills with potentially fatal side-effects for reasons that make no medical sense.Welearned on Monday that the president has been taking the malaria drug hydroxychloroqu...
Source: Guardian Unlimited Science - May 19, 2020 Category: Science Authors: Arwa Mahdawi Tags: Donald Trump Coronavirus outbreak Infectious diseases Medical research Microbiology Science US news World news Source Type: news

President Trump taking unproven drug to prevent COVID-19
President Trump says he is taking the anti-malaria drug hydroxychloroquine to prevent himself from getting COVID-19. The drug is unproven as a treatment for the virus and the FDA has warned it could have dangerous side effects. CBS News medical contributor Dr. David Agus explains the potential benefits and risks of the drug. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 19, 2020 Category: Consumer Health News Source Type: news

Trump's use of malaria drug likely to be welcomed in India
President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India (Source: ABC News: Health)
Source: ABC News: Health - May 19, 2020 Category: Consumer Health News Tags: Health Source Type: news

Trump says he is taking hydroxychloroquine despite FDA warning
U.S. President Donald Trump, in a surprise announcement, said on Monday he is taking hydroxychloroquine as a preventive medicine against the coronavirus despite medical warnings about the use of the malaria drug. (Source: Reuters: Health)
Source: Reuters: Health - May 19, 2020 Category: Consumer Health News Tags: healthNews Source Type: news